Article
Licensed
Unlicensed
Requires Authentication
A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease
-
Laura Guerrero
Published/Copyright:
November 18, 2010
Abstract
Background: Chagas disease is endemic in Latin America, affecting 16–18 million people with more than 100 million exposed to risk of infection. Its etiological agent is Trypanosoma cruzi. To date, benznidazole is the only treatment of Chagas disease available in Europe.
Methods: A high-performance reversed-phase isocratic liquid chromatographic method for benznidazole analysis in human plasma is described. The mobile phase consists of 60% ultrafiltered water and 40% acetonitrile. Samples were precipitated with trichloroacetic acid (0.3 M) (1/1, v/v). The injection volume was 100 μL. Benzocaine was used as internal standard.
Results: The assay was linear over a benznidazole concentration range of 1.6–100 μg/mL. The method showed good agreement of results (n=15): inaccuracy (5.6%), intra- and inter-day variability (1.1% and 3.9%, respectively), recovery (94.9%), limit of detection (0.8 μg/mL), lower limit of quantitation (1.6 μg/mL) and acceptable stability over 24 h in the auto-sampler. Only 25 samples (58%) showed values within the therapeutic range. Three samples were subtherapeutic and 15 were in the toxic range.
Conclusions: The method offers a fast and simple approach to determining benznidazole in human plasma which could be of use in pharmacokinetic and safety studies.
Keywords: analytics; benznidazole; Chagas disease; high pressure liquid chromatography; human plasma; validation
Received: 2010-5-26
Accepted: 2010-7-21
Published Online: 2010-11-18
Published in Print: 2011-01-01
©2011 by Walter de Gruyter Berlin New York
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Publisher's Note
- Publisher's Note
- Editorials
- Full-Disclosure in Industry-Sponsored Laboratory Medicine Research Studies: Statement by the Consortium of Laboratory Medicine Journal Editors
- Association of malignant mesothelioma and asbestos related conditions with ovarian cancer: shared biomarkers and a possible etiological link?
- Pharmacogenomics of alcohol metabolism: implications for legal testing
- Reviews
- Non-invasive assessment of liver fibrosis: it is time for laboratory medicine
- Application of proteomics to prenatal screening and diagnosis for aneuploidies
- Opinion Paper
- Harmonization of free thyroid hormone tests: a mission impossible?
- Genetics and Molecular Diagnostics
- A polymorphism in the 5’ UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients
- Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population
- General Clinical Chemistry and Laboratory Medicine
- Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis
- Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application
- A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease
- Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies
- Interlaboratory study of free monoclonal immunoglobulin light chain quantification
- Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease
- Testosterone is an independent determinant of bone mineral density in men with type 2 diabetes mellitus
- Introduction of a new cobalamin (vitamin B12) assay: lessons from a flawed validation study
- Prevalence and course of pseudothrombocytopenia in outpatients
- Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis
- Validation and Outcome Studies Reference Values and Biological Variations
- Age- and gender-dependent changes in circulating concentrations of tumor necrosis factor-α, soluble tumor necrosis factor receptor-1 and sulfated glycosaminoglycan in healthy people
- Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity
- Cross-sectional study of biomarkers of exposure and biological effect on monozygotic twins discordant for smoking
- Cancer Diagnostics
- Evaluation of ovarian cancer biomarkers in subjects with benign asbestos-related pleural diseases
- Development of a fluorescent microsphere immunoassay for cystatin B (CSTB) in serum of patients with hepatocellular carcinoma
- Letters to the Editor
- Factors reducing hemolysis rates in blood samples from the emergency department
- Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury
- Crystal-associated pseudoeosinophilia of synovial fluid
Keywords for this article
analytics;
benznidazole;
Chagas disease;
high pressure liquid chromatography;
human plasma;
validation
Articles in the same Issue
- Publisher's Note
- Publisher's Note
- Editorials
- Full-Disclosure in Industry-Sponsored Laboratory Medicine Research Studies: Statement by the Consortium of Laboratory Medicine Journal Editors
- Association of malignant mesothelioma and asbestos related conditions with ovarian cancer: shared biomarkers and a possible etiological link?
- Pharmacogenomics of alcohol metabolism: implications for legal testing
- Reviews
- Non-invasive assessment of liver fibrosis: it is time for laboratory medicine
- Application of proteomics to prenatal screening and diagnosis for aneuploidies
- Opinion Paper
- Harmonization of free thyroid hormone tests: a mission impossible?
- Genetics and Molecular Diagnostics
- A polymorphism in the 5’ UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients
- Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population
- General Clinical Chemistry and Laboratory Medicine
- Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis
- Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application
- A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease
- Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies
- Interlaboratory study of free monoclonal immunoglobulin light chain quantification
- Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease
- Testosterone is an independent determinant of bone mineral density in men with type 2 diabetes mellitus
- Introduction of a new cobalamin (vitamin B12) assay: lessons from a flawed validation study
- Prevalence and course of pseudothrombocytopenia in outpatients
- Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis
- Validation and Outcome Studies Reference Values and Biological Variations
- Age- and gender-dependent changes in circulating concentrations of tumor necrosis factor-α, soluble tumor necrosis factor receptor-1 and sulfated glycosaminoglycan in healthy people
- Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity
- Cross-sectional study of biomarkers of exposure and biological effect on monozygotic twins discordant for smoking
- Cancer Diagnostics
- Evaluation of ovarian cancer biomarkers in subjects with benign asbestos-related pleural diseases
- Development of a fluorescent microsphere immunoassay for cystatin B (CSTB) in serum of patients with hepatocellular carcinoma
- Letters to the Editor
- Factors reducing hemolysis rates in blood samples from the emergency department
- Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury
- Crystal-associated pseudoeosinophilia of synovial fluid
